In this chapter, we learn that the company has spent a lot of money and time on a new drug, and that the results are not good. The company's scientists have been working on the drug for six months, and it is still not ready for commercialization. If the drug passes the drug safety inspection, the company will be able to sell it to the public. But if the drug does not pass the inspection, then the company is liable for the damages caused by the failure.